Pharmaceutical composition including a DHA ester to be parenterally administered

Details for Australian Patent Application No. 2010283754 (hide)

Owner Pierre Fabre Medicament

Inventors Leverd, Elie; Van Hoogevest, Peter; Kung, Elsa; Leigh, Mathew

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010283754

PCT Pub. Number WO2011/018480

Priority 0955612 11.08.09 FR

Filing date 11 August 2010

Wipo publication date 17 February 2011

International Classifications

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/232 (2006.01)

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

Event Publications

8 March 2012 PCT application entered the National Phase

  PCT publication WO2011/018480 Priority application(s): WO2011/018480

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010283761-Sigma ligands for the prevention or treatment of pain induced by chemotherapy

2010283753-Absorbent composition and process for removing CO2 and/or H2S from a gas comprising CO2 and /or H2S